These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17331837)

  • 1. Atlas of breast magnetic resonance imaging.
    Hirose M; Hashizume T; Seino N; Kubota H; Nobusawa H; Gokan T
    Curr Probl Diagn Radiol; 2007; 36(2):51-65. PubMed ID: 17331837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation.
    Iglesias A; Arias M; Santiago P; Rodríguez M; Mañas J; Saborido C
    Curr Probl Diagn Radiol; 2007; 36(2):66-82. PubMed ID: 17331838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual malignant tumors of the breast: MRI features and pathologic correlation.
    Linda A; Zuiani C; Girometti R; Londero V; Machin P; Brondani G; Bazzocchi M
    Eur J Radiol; 2010 Aug; 75(2):178-84. PubMed ID: 19446418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of benign phyllodes tumors of the breast.
    Kinoshita T; Fukutomi T; Kubochi K
    Breast J; 2004; 10(3):232-6. PubMed ID: 15125750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast magnetic resonance imaging for preoperative locoregional staging.
    Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
    Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge.
    Hirose M; Nobusawa H; Gokan T
    Radiographics; 2007 Oct; 27 Suppl 1():S183-96. PubMed ID: 18180226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of breast cancer: MDCT versus MRI.
    Tozaki M
    Breast Cancer; 2008; 15(3):205-11. PubMed ID: 18443898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Typical and unusual findings in MR mammography].
    Bick U
    Rofo; 2000 May; 172(5):415-28. PubMed ID: 10874968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast MRI: state of the art.
    Vandermeer FQ; Bluemke DA
    Cancer Invest; 2007 Sep; 25(6):384-92. PubMed ID: 17882648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive detection and visualization of breast lesions from dynamic contrast enhanced MRI volumes.
    Subramanian KR; Brockway JP; Carruthers WB
    Comput Med Imaging Graph; 2004 Dec; 28(8):435-44. PubMed ID: 15541950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of breast diseases with magnetic resonance tomography].
    Kvistad KA; Gribbestad IS; Haraldseth O; Nilsen G
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1451-8. PubMed ID: 10851944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of current evidence-based clinical applications for breast magnetic resonance imaging.
    DeMartini W; Lehman C
    Top Magn Reson Imaging; 2008 Jun; 19(3):143-50. PubMed ID: 18941394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of a fibroadenoma coexisting with an invasive lobular carcinoma in the breast.
    Tajima S; Kanemaki Y; Kurihara Y; Okamoto K; Shimamoto H; Okazaki H; Okuda I; Kawahara F; Nakajima Y; Fukuda M; Maeda I
    Breast Cancer; 2011 Oct; 18(4):319-23. PubMed ID: 19543793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of suspicious nipple discharge by magnetic resonance mammography based on breast imaging reporting and data system magnetic resonance imaging descriptors.
    Tokuda Y; Kuriyama K; Nakamoto A; Choi S; Yutani K; Kunitomi Y; Haneda T; Kawai M; Masuda N; Takeda M; Nakamura H
    J Comput Assist Tomogr; 2009; 33(1):58-62. PubMed ID: 19188786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
    Uematsu T; Kasami M; Yuen S
    Breast Cancer; 2009; 16(2):97-104. PubMed ID: 18663562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
    Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD
    J Clin Oncol; 2008 Jan; 26(3):386-91. PubMed ID: 18202414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of the human breast: a Phase I trial.
    El Yousef SJ; Duchesneau RH
    Radiol Clin North Am; 1984 Dec; 22(4):859-68. PubMed ID: 6096921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should have breast magnetic resonance imaging evaluation?
    Orel S
    J Clin Oncol; 2008 Feb; 26(5):703-11. PubMed ID: 18258977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.